New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer patients

New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer patients retrieved 16 April 2024 from https://medicalxpress.com/news/2024-04-spectct-technique-biomarker-identification-access.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.11 hours agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Advancements in CAR-T Therapy: Utilizing Antigen Multimers for Improved Workflow AutomationThe ability to engineer immune cells is at the leading edge of cancer treatment. CAR-T therapy has effectively treated relapsed or refractory hematological malignancies. CAR-T's continued growth has created a requirement for CAR cell-related reagents and tools. Antigen multimers, such as pre-coupled magnetic multimers, are precise and accurate in CAR cell activation, detection, expansion, enrichment, and ex vivo analysis.
Source: NewsMedical - 🏆 19. / 71 Read more »

Utilizing meta-analysis of tumor marker blood test kinetics in ovarian cancer patientsPatient prognosis and treatment response prediction are key factors in treating ovarian cancer, which is characterized by the lowest survival rate among gynecological cancers. Consequently, there is strong demand for a more reliable prognostic marker.
Source: medical_xpress - 🏆 101. / 51 Read more »